Claritev Corporation, the NYSE-listed healthcare analytics company trading as CTEV, has invested in Klaim, Inc., an AI-driven payment acceleration provider. The deal underpins a co-branded Payment Acceleration Service that will be embedded into Claritev’s network across the United States and the Middle East and North Africa. Both companies position the move as a way to deliver faster, more predictable reimbursements to healthcare providers that often wait months for payment.
Strategic Rationale
Claritev is using the investment to extend its footprint in the MENA region while supporting Klaim’s expansion across the U.S. market. The companies intend to combine Claritev’s payer-provider infrastructure and analytics with Klaim’s funding rails to improve working capital for providers. The partnership aims to set a new standard for liquidity access and operational efficiency in healthcare finance.
Product and Integration
The Claritev–Klaim platform allows eligible providers to convert pending insurance claims into near-instant liquidity rather than waiting the typical 30 to 120 days. Claims will be evaluated using Claritev’s Advanced Code Editing technology to determine which are suitable for funding. Klaim’s software then advances funds and manages the downstream reconciliation and payer follow-up on accelerated claims.
Provider Impact and Benefits
Participating providers are expected to gain certainty of payment for qualifying claims, which can reduce cash flow gaps caused by denials and delays. The service is designed to be flexible so organizations can choose how many claims to accelerate based on working capital needs. Administrative workloads should also decline as Klaim assumes reconciliation tasks while maintaining scalability for clinics, hospitals, and multi-specialty networks.
Market Expansion and Structure
The arrangement is framed as a bridge between Claritev’s U.S. presence and Klaim’s healthcare-fintech expertise rooted in the Middle East. By operating in both the U.S. and MENA, the combined service targets fragmented reimbursement timelines that constrain provider liquidity. Klaim also disclosed that the investment initiates a global restructuring plan intended to align Klaim Middle East and Klaim, Inc. under a future holding company.
Leadership Commentary
Will Mintz, Chief Strategy Officer at Claritev, said the investment reflects a commitment to modernizing provider cash flow and strengthening financial resilience. He emphasized the pairing of Claritev’s provider relationships and ACE technology with Klaim’s fintech infrastructure to speed payments and improve confidence. Karim Dakki, Co-Founder and CEO of Klaim, described the collaboration as a data-driven way to turn delayed reimbursements into predictable cash flow so practices can focus on care.
Company Profiles
Claritev describes itself as a healthcare technology, data, and insights company focused on affordability, transparency, and quality. The company cites more than 40 years of claims repricing experience and an enterprise platform used by over 700 healthcare payers, 100,000 employers, 60 million consumers, and 1.4 million contracted providers. Klaim was founded by Karim Dakki and Ghafoor Ahmad to help providers accelerate reimbursements within 24 hours using proprietary AI-powered funding tools.
With the new investment, Claritev and Klaim are building a payments utility that seeks to collapse reimbursement timelines and reduce administrative friction. If execution matches intent, providers could gain faster access to working capital and improved predictability while offloading back-office burdens. The cross-regional strategy further signals growing convergence between healthcare analytics and embedded fintech solutions in provider finance.